On the stock market since 2013, it operates in the world of health and science. It has 596 employees. Now — the numbers.
The company closed last year at a loss: costs ran above sales. The picture changes only if spending is reined in.
An average decline of 9% a year over the last 4 years — the most striking risk in this picture. Red columns mark years that ended in a loss.
Before the clock runs out, either sales must climb sharply or new money must come in. For now, time is on the company’s side.
angles, checked one by one.
The 2 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Bets Against the Stock: The number of investors betting on a fall stands out.
The stock trades 58% below its peak. The market has trimmed its expectations for the company.
The company sells $38.8M a year; the problem isn’t sales — it’s costs running above that number.
There is $51.7M in the vault; even if every debt were paid off, $49.6M would remain.
A loss of $12.6M against $38.8M in annual sales.
The stock sits at $0.15. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
On our five-subject report card, CLIFF sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: CLIFF is a small company that closed last year at a loss. The road back to profit runs through spending discipline.